TGOD.TO C$0.17 Green Organic Dutchman TSX pre-market Mar 12: Most active, watch

TGOD.TO stock opened pre-market at C$0.26 and is quoted at C$0.17 as of the latest TSX snapshot on 12 Mar 2026. Trading is heavy with 19,704,275 shares changing hands today, far above the average volume of 1,585,835. The share price sits below the 50-day average of C$0.24 and well under the 200-day average of C$0.31. We examine why volume is spiking, link fundamentals to price action, and highlight technical levels traders are watching.

TGOD.TO stock: pre-market price and volume snapshot

TGOD.TO stock trades at C$0.17 with a day low of C$0.17 and a day high of C$0.22. Volume is 19,704,275, a relative volume of 12.43, showing outsized intraday interest on the TSX in Canada. The price sits near the 52-week low of C$0.17 and well below the 52-week high of C$0.65.

TGOD.TO stock: fundamentals and key metrics

TGOD.TO stock shows trailing EPS of -0.23 and a negative P/E of -0.74, reflecting losses at The Green Organic Dutchman. Book value per share is C$0.38 and price-to-book is 0.45, implying the market values the company below book. Current ratio is 0.67, and debt-to-equity is 0.33, indicating short-term liquidity pressure with manageable leverage.

TGOD.TO stock: technicals and trading levels

TGOD.TO stock is below the 50-day average C$0.24 and 200-day average C$0.31, a bearish technical backdrop. Short-term support sits at C$0.17 and resistance at C$0.22 and C$0.24. Average daily volume is 1,585,835, so today’s 19,704,275 volume signals large orders or block trades influencing price discovery.

TGOD.TO stock: sector context and risks

TGOD.TO stock operates in the Healthcare sector and the Drug Manufacturers – Specialty & Generic industry in Canada. The sector shows weaker performance year-to-date versus broader markets, increasing sector risk for small-cap cannabis names. Operational risks include long inventory cycles (days of inventory 453.70) and extended receivables (DSO 172.91), which pressure cash conversion.

TGOD.TO stock: Meyka AI grade and analyst framing

Meyka AI rates TGOD.TO with a score out of 100: 63.07 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The score reflects weak profitability but reasonable book value and limited leverage.

TGOD.TO stock: price targets, forecast and scenarios

Meyka AI’s forecast model projects a monthly level of C$0.17, matching the current price and implying 0.00% upside on the near-term model projection; forecasts are model-based and not guarantees. Practical scenarios: base case target C$0.35 (about +105.88% from C$0.17) if revenue and distribution expand; conservative target C$0.10 (about -41.18%) if liquidity tightens; bull case equals the 52-week high C$0.65 (about +282.35%). These targets are for planning, not recommendations.

Final Thoughts

TGOD.TO stock shows heavy pre-market interest on 12 Mar 2026 with C$0.17 pricing and unusually high 19,704,275 volume, driven by liquidity flows rather than fresh earnings data. Fundamentals show negative EPS -0.23, low current ratio 0.67, and long inventory cycles, all of which increase operational risk for this Canadian TSX-listed cannabis producer. Technically, the stock trades below both the 50-day and 200-day averages, with immediate resistance at C$0.22 and C$0.24. Meyka AI’s model projects C$0.17 near-term, implying no immediate upside from the model baseline; traders should weigh the company’s price-to-book 0.45 and enterprise value to sales 1.63 when sizing positions. For risk-managed exposure consider defined entry limits and a clear stop below C$0.17. Remember, Meyka AI is an AI-powered market analysis platform and our forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.